On Tuesday, 9th of October 2012, Malcisbo was granted the precious CTI Start-up Label form the Commission for Technology and Innovation CTI. This Label certifies that Malcisbo has successfully completed the CTI Start-up Coaching program and is now ready for Venture financing.
Malcisbo wins the prestigious Swiss Technology Award in the category “seed” for their pioneering vaccine platform based on carbohydrates (“sweet vaccines”).
Malcisbo has successfully closed its seed financing round. The initial target of CHF 2.4 Mio. was substantially exceeded. Private investors, Business Angels, Zürcher Kantonalbank Startup Finance and Redalpine Venture Partners AG have invested in total a sum of CHF 3.6 Mio in the company. In parallel the company was granted a substantial research contribution by CTI.
Malcisbo is presented in Swiss Venture Guide 2011. This guide for Swiss high tech companies is a joint effort of CTI Invest & CTI and reports about Malcisbo as one of 10 companies on the way to success.
Venture 2010: Malcisbo wins the 2nd prize of Venture 2010 second phase and presents its projects at the award ceremony at ETH Zurich. Malcisbo was already one of the 10 winners of Venture 2010 first phase in January 2010.